Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (542)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
139
2024
3035
9.200
Why?
Hematopoietic Stem Cell Transplantation
27
2024
573
3.750
Why?
Pyrazines
20
2023
203
2.870
Why?
Boronic Acids
19
2014
197
2.650
Why?
Thalidomide
28
2023
397
2.610
Why?
Antineoplastic Combined Chemotherapy Protocols
34
2024
1056
2.520
Why?
Antineoplastic Agents
29
2020
1300
1.990
Why?
Transplantation, Autologous
27
2024
476
1.860
Why?
Transplantation Conditioning
9
2019
86
1.590
Why?
Drug Resistance, Neoplasm
16
2020
309
1.560
Why?
Paraproteinemias
8
2018
80
1.380
Why?
Neoplastic Stem Cells
5
2020
103
1.270
Why?
Humans
149
2024
54284
1.170
Why?
Protease Inhibitors
6
2011
64
1.160
Why?
Venous Thrombosis
7
2009
102
1.110
Why?
Angiogenesis Inhibitors
9
2009
203
1.050
Why?
Melphalan
15
2023
180
1.030
Why?
Hematopoietic Stem Cell Mobilization
5
2014
61
1.010
Why?
Gene Expression Regulation, Neoplastic
13
2020
866
0.990
Why?
Aged
57
2023
10054
0.990
Why?
Busulfan
3
2019
18
0.920
Why?
Alkaline Phosphatase
5
2011
99
0.910
Why?
Prognosis
31
2024
2118
0.900
Why?
Stem Cell Transplantation
12
2023
196
0.870
Why?
Middle Aged
56
2023
13088
0.870
Why?
Plasma Cells
10
2023
238
0.820
Why?
Treatment Outcome
37
2022
5604
0.790
Why?
Dexamethasone
15
2024
435
0.760
Why?
Thromboembolism
3
2009
56
0.710
Why?
Male
63
2021
27334
0.670
Why?
Neoplasm Proteins
6
2021
359
0.670
Why?
Female
59
2021
28441
0.630
Why?
Immunoglobulin Light Chains
3
2016
101
0.620
Why?
Bone Remodeling
2
2010
177
0.600
Why?
Anticoagulants
5
2009
270
0.600
Why?
Blood Transfusion
1
2018
138
0.590
Why?
Immunologic Factors
5
2012
130
0.580
Why?
Gene Expression Profiling
18
2023
1138
0.580
Why?
Cell Line, Tumor
18
2023
1550
0.550
Why?
Receptors, Retinoic Acid
2
2013
27
0.550
Why?
Follow-Up Studies
21
2024
2387
0.540
Why?
IMP Dehydrogenase
2
2006
4
0.540
Why?
Proteasome Inhibitors
6
2018
110
0.540
Why?
Mycophenolic Acid
2
2006
17
0.540
Why?
Survival Rate
16
2019
951
0.520
Why?
Clinical Trials as Topic
8
2022
490
0.510
Why?
Cell Proliferation
15
2020
1096
0.500
Why?
Adult
37
2018
14207
0.500
Why?
Antineoplastic Agents, Alkylating
6
2008
74
0.500
Why?
Recurrence
15
2018
690
0.490
Why?
Up-Regulation
5
2020
508
0.480
Why?
Osteogenesis
3
2012
377
0.470
Why?
Chromosome Aberrations
7
2008
316
0.470
Why?
Venous Thromboembolism
3
2011
75
0.470
Why?
Disease-Free Survival
11
2019
485
0.470
Why?
Retrospective Studies
18
2024
6432
0.470
Why?
Combined Modality Therapy
12
2008
692
0.470
Why?
Apoptosis
9
2019
1300
0.460
Why?
Doxorubicin
8
2018
259
0.460
Why?
Antibodies, Monoclonal
3
2015
562
0.460
Why?
Disease Progression
12
2019
913
0.450
Why?
Animals
30
2024
14385
0.450
Why?
Signal Transduction
12
2020
1753
0.450
Why?
Survival Analysis
11
2021
735
0.450
Why?
Antigens, Neoplasm
4
2007
170
0.440
Why?
Bone Diseases
3
2012
109
0.440
Why?
Central Nervous System Neoplasms
2
2004
57
0.440
Why?
Thrombosis
4
2012
243
0.440
Why?
Myeloablative Agonists
5
2014
33
0.420
Why?
Transplantation, Homologous
6
2004
155
0.410
Why?
Oligopeptides
2
2013
95
0.410
Why?
Bone Marrow
7
2022
411
0.410
Why?
T-Lymphocytes
9
2024
373
0.410
Why?
Osteoblasts
4
2007
514
0.400
Why?
Hematopoietic Stem Cells
2
2010
215
0.390
Why?
Risk Factors
18
2018
3935
0.390
Why?
Meta-Analysis as Topic
2
2015
39
0.380
Why?
Salvage Therapy
9
2012
145
0.380
Why?
Granulocyte Colony-Stimulating Factor
2
2008
69
0.380
Why?
Chromosomes, Human, Pair 13
4
2008
41
0.380
Why?
Ultrasonography, Doppler
2
2007
57
0.360
Why?
Enzyme Inhibitors
2
2019
446
0.360
Why?
Membrane Proteins
4
2017
389
0.360
Why?
Mice
19
2024
6413
0.360
Why?
Neoplasm, Residual
4
2022
166
0.350
Why?
Remission Induction
9
2008
221
0.340
Why?
Cell Cycle Proteins
2
2021
199
0.340
Why?
B-Lymphocytes
4
2021
176
0.340
Why?
Prospective Studies
9
2019
2604
0.340
Why?
Myelodysplastic Syndromes
3
2007
79
0.340
Why?
Waldenstrom Macroglobulinemia
3
2018
41
0.340
Why?
Lymphoma, B-Cell
3
2021
62
0.330
Why?
Immunosuppressive Agents
3
2005
248
0.330
Why?
Bone Neoplasms
1
2010
193
0.330
Why?
Neovascularization, Pathologic
1
2009
168
0.320
Why?
Brain Diseases, Metabolic
1
2007
7
0.310
Why?
Hyperammonemia
1
2007
18
0.300
Why?
Proteasome Endopeptidase Complex
4
2018
131
0.300
Why?
Monoclonal Gammopathy of Undetermined Significance
3
2023
108
0.300
Why?
Farnesyltranstransferase
1
2006
5
0.300
Why?
Thrombophilia
4
2009
20
0.300
Why?
Amyloidosis
2
2007
85
0.300
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
57
0.290
Why?
Small Molecule Libraries
2
2019
72
0.290
Why?
Hemostasis
1
2007
56
0.290
Why?
Dose-Response Relationship, Drug
6
2016
1476
0.290
Why?
Aged, 80 and over
11
2019
3431
0.290
Why?
Research Design
1
2009
374
0.290
Why?
Immunotherapy, Adoptive
4
2024
134
0.290
Why?
Bone and Bones
1
2010
516
0.290
Why?
Sirolimus
1
2006
65
0.280
Why?
Gastrointestinal Neoplasms
1
2006
46
0.280
Why?
Cell Survival
8
2018
657
0.270
Why?
In Situ Hybridization, Fluorescence
6
2016
278
0.270
Why?
Diploidy
2
2004
30
0.260
Why?
Caspases
1
2006
146
0.260
Why?
Flow Cytometry
6
2018
546
0.260
Why?
Antibody Formation
1
2005
69
0.260
Why?
Activated Protein C Resistance
4
2011
10
0.260
Why?
Killer Cells, Natural
3
2012
107
0.250
Why?
Religion
1
2005
68
0.250
Why?
Enoxaparin
1
2004
25
0.250
Why?
Chromosome Deletion
2
2008
150
0.250
Why?
Aneuploidy
1
2004
23
0.250
Why?
Ubiquitination
2
2021
47
0.240
Why?
Adaptation, Psychological
1
2005
244
0.240
Why?
Attitude to Health
1
2005
226
0.230
Why?
Osteolysis
2
2022
88
0.230
Why?
Pyrimidines
3
2015
196
0.230
Why?
Randomized Controlled Trials as Topic
4
2012
596
0.220
Why?
Cancer Vaccines
3
2010
103
0.220
Why?
Blood Coagulation
1
2003
69
0.220
Why?
Mice, Inbred NOD
6
2020
99
0.220
Why?
Antigens, CD34
1
2003
80
0.220
Why?
Graft vs Host Disease
5
2010
83
0.220
Why?
Leukemia, Myeloid
1
2002
54
0.210
Why?
STAT3 Transcription Factor
4
2015
87
0.210
Why?
Critical Illness
1
2005
344
0.210
Why?
Chromosome Disorders
1
2002
39
0.210
Why?
Bone Resorption
2
2022
326
0.210
Why?
Parathyroid Hormone
3
2010
196
0.210
Why?
Case-Control Studies
9
2018
1228
0.210
Why?
Neoplasms, Second Primary
1
2002
77
0.200
Why?
Hypothyroidism
1
2002
53
0.200
Why?
Antibodies, Bispecific
1
2022
43
0.200
Why?
Kidney
1
2007
820
0.200
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
93
0.200
Why?
Chromosomes, Human, Pair 1
3
2006
113
0.200
Why?
Neoplasm Recurrence, Local
4
2024
644
0.190
Why?
Xenograft Model Antitumor Assays
5
2019
219
0.180
Why?
Multivariate Analysis
4
2008
643
0.180
Why?
Glucuronidase
2
2018
48
0.180
Why?
DNA-Binding Proteins
2
2020
462
0.180
Why?
Neoplasms
2
2009
1316
0.180
Why?
Cisplatin
5
2009
352
0.170
Why?
Predictive Value of Tests
5
2009
1048
0.170
Why?
Bone Marrow Transplantation
4
2007
149
0.170
Why?
Syndecan-1
3
2017
82
0.170
Why?
Cytotoxicity, Immunologic
2
2012
62
0.170
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
158
0.170
Why?
Healthcare Disparities
1
2022
271
0.170
Why?
Hydrocarbons, Aromatic
1
2018
3
0.170
Why?
Kaplan-Meier Estimate
6
2015
514
0.170
Why?
Drug Tolerance
1
2018
60
0.170
Why?
Solvents
1
2018
35
0.170
Why?
Jehovah's Witnesses
1
2018
7
0.160
Why?
Tumor Microenvironment
2
2023
209
0.160
Why?
Cytogenetic Analysis
5
2007
90
0.160
Why?
Pyridines
1
2019
137
0.160
Why?
Time Factors
8
2016
3213
0.160
Why?
Vincristine
3
2003
98
0.160
Why?
Cyclophosphamide
3
2003
172
0.160
Why?
CDC2-CDC28 Kinases
2
2015
15
0.160
Why?
Platelet Count
3
2008
77
0.160
Why?
Cell Differentiation
4
2022
720
0.160
Why?
Cytokines
3
2007
676
0.160
Why?
beta 2-Microglobulin
3
2008
35
0.150
Why?
Logistic Models
4
2018
995
0.150
Why?
Occupational Diseases
1
2018
93
0.150
Why?
Iron
2
2017
158
0.150
Why?
Etoposide
4
2009
85
0.150
Why?
Dendritic Cells
2
2010
142
0.150
Why?
Risk Assessment
5
2023
1361
0.150
Why?
Drug Combinations
1
2017
128
0.150
Why?
Pyruvate Kinase
1
2017
8
0.150
Why?
Ascorbic Acid
1
2017
33
0.150
Why?
Mice, SCID
5
2018
196
0.150
Why?
Interleukin-6
2
2018
315
0.150
Why?
Occupational Exposure
1
2018
129
0.150
Why?
Anthropometry
1
2017
96
0.150
Why?
RNA Splicing
1
2017
38
0.150
Why?
Glycolysis
1
2017
73
0.140
Why?
Factor V
3
2011
11
0.140
Why?
Immunoglobulin lambda-Chains
1
2016
18
0.140
Why?
Immunoglobulin kappa-Chains
1
2016
31
0.140
Why?
Tumor Cells, Cultured
6
2019
477
0.140
Why?
Transcription Factors
1
2020
622
0.140
Why?
Fibrinolytic Agents
2
2007
139
0.140
Why?
Reproductive History
1
2015
4
0.140
Why?
Incidence
3
2009
1082
0.140
Why?
Leukocytes, Mononuclear
2
2014
133
0.140
Why?
Oncolytic Virotherapy
1
2015
18
0.140
Why?
MicroRNAs
1
2020
386
0.140
Why?
Hormone Replacement Therapy
1
2015
27
0.140
Why?
Cyclopentanes
1
2015
14
0.130
Why?
Cell Adhesion Molecules
1
2015
87
0.130
Why?
Ubiquitins
1
2015
40
0.130
Why?
Hemorrhage
2
2007
208
0.130
Why?
Cation Transport Proteins
1
2015
28
0.130
Why?
Receptors, Cell Surface
1
2015
130
0.130
Why?
Aldehyde Dehydrogenase
1
2014
27
0.130
Why?
Immunotherapy
3
2006
263
0.130
Why?
Postmenopause
1
2015
102
0.130
Why?
Hematologic Neoplasms
1
2016
99
0.130
Why?
Drug Monitoring
1
2015
85
0.130
Why?
NF-kappa B
3
2018
335
0.130
Why?
Osteoclasts
3
2022
469
0.130
Why?
Leukapheresis
1
2014
16
0.120
Why?
Transplantation Chimera
3
2003
15
0.120
Why?
Protein-Tyrosine Kinases
1
2015
101
0.120
Why?
Translocation, Genetic
3
2005
287
0.120
Why?
Myeloma Proteins
2
2020
26
0.120
Why?
Intestines
1
2016
204
0.120
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.120
Why?
Veratrum Alkaloids
1
2013
5
0.120
Why?
Gene Deletion
3
2004
293
0.120
Why?
Antibodies
2
2024
178
0.120
Why?
Multidrug Resistance-Associated Proteins
1
2013
19
0.120
Why?
Isoxazoles
1
2013
16
0.120
Why?
Body Mass Index
1
2017
713
0.120
Why?
Sulfones
1
2013
24
0.120
Why?
Hedgehog Proteins
1
2013
33
0.120
Why?
Cystatin M
2
2024
21
0.120
Why?
Itraconazole
1
2013
45
0.120
Why?
Polymorphism, Single Nucleotide
1
2016
552
0.120
Why?
B-Cell Maturation Antigen
2
2024
72
0.120
Why?
Metaphase
3
2008
55
0.120
Why?
Intercellular Adhesion Molecule-1
1
2013
75
0.110
Why?
Biopsy
2
2006
692
0.110
Why?
Carrier Proteins
2
2017
359
0.110
Why?
Genetic Predisposition to Disease
1
2016
570
0.110
Why?
T-Lymphocytes, Cytotoxic
2
2010
72
0.110
Why?
Wnt Proteins
1
2013
110
0.110
Why?
Renal Insufficiency
3
2009
138
0.110
Why?
Risk
2
2011
343
0.110
Why?
Viremia
1
2012
25
0.110
Why?
Drug Delivery Systems
2
2005
151
0.110
Why?
Cytomegalovirus Infections
1
2012
46
0.110
Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
51
0.100
Why?
Receptors, KIR
2
2008
15
0.100
Why?
Reoperation
2
2004
454
0.100
Why?
Fluorodeoxyglucose F18
2
2021
205
0.100
Why?
Radiopharmaceuticals
2
2021
238
0.100
Why?
Medical Oncology
1
2012
102
0.100
Why?
Phosphorylation
2
2020
614
0.100
Why?
Ligands
2
2009
230
0.100
Why?
Drug Evaluation, Preclinical
1
2012
158
0.100
Why?
Alcohol Drinking
1
2013
259
0.100
Why?
Inflammation
1
2016
674
0.100
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.100
Why?
Arsenicals
1
2010
14
0.100
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
21
0.100
Why?
Oxides
1
2010
19
0.100
Why?
Age Factors
3
2005
1198
0.100
Why?
Antineoplastic Agents, Hormonal
2
2007
49
0.090
Why?
Janus Kinase 1
1
2010
20
0.090
Why?
Recombinant Proteins
2
2010
569
0.090
Why?
Smoking
1
2014
556
0.090
Why?
MAP Kinase Kinase 1
1
2010
26
0.090
Why?
Cyclin-Dependent Kinases
1
2010
35
0.090
Why?
Authorship
1
2010
14
0.090
Why?
Macrophages
1
2013
405
0.090
Why?
Down-Regulation
2
2010
388
0.090
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
101
0.090
Why?
Conflict of Interest
1
2010
24
0.090
Why?
Drug Industry
1
2010
40
0.090
Why?
Neoplasm Staging
3
2015
806
0.090
Why?
Disclosure
1
2010
39
0.090
Why?
Bone Density Conservation Agents
1
2010
83
0.090
Why?
Diphosphonates
1
2010
96
0.090
Why?
Chromosome Banding
2
2006
28
0.090
Why?
Leukocyte Count
2
2014
77
0.090
Why?
Maximum Tolerated Dose
2
2009
37
0.090
Why?
Plasmacytoma
2
2011
47
0.090
Why?
Mice, Transgenic
3
2021
656
0.090
Why?
Periodicals as Topic
1
2010
65
0.080
Why?
Tretinoin
1
2009
56
0.080
Why?
Cryoglobulinemia
1
2008
12
0.080
Why?
Cell Cycle
2
2010
275
0.080
Why?
Magnetic Resonance Imaging
3
2007
1604
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
474
0.080
Why?
Blotting, Western
3
2015
683
0.080
Why?
Cytogenetics
1
2008
28
0.080
Why?
Prednisone
2
2009
111
0.080
Why?
Neutrophils
2
2014
154
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
230
0.080
Why?
Pulmonary Embolism
1
2009
106
0.080
Why?
Hemoglobins
1
2008
126
0.080
Why?
Immunophenotyping
2
2007
117
0.080
Why?
Sulfonamides
1
2009
146
0.080
Why?
Polyethylene Glycols
1
2008
106
0.080
Why?
Adoptive Transfer
1
2007
38
0.080
Why?
Heparin, Low-Molecular-Weight
1
2007
21
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
673
0.080
Why?
Histocompatibility Antigens Class I
1
2007
52
0.080
Why?
Phlebography
1
2007
70
0.080
Why?
Fibrinolysis
1
2007
8
0.080
Why?
Ammonia
1
2007
73
0.080
Why?
Blood Coagulation Factors
1
2007
19
0.070
Why?
Chi-Square Distribution
1
2007
318
0.070
Why?
Biomedical Research
1
2010
240
0.070
Why?
Osteoprotegerin
1
2006
57
0.070
Why?
Drug Administration Schedule
2
2006
401
0.070
Why?
Cell Membrane
1
2007
278
0.070
Why?
Guanosine
1
2006
6
0.070
Why?
Brain
2
2007
1387
0.070
Why?
Antibiotics, Antineoplastic
1
2006
85
0.070
Why?
Models, Genetic
1
2006
209
0.070
Why?
Sex Factors
3
2016
767
0.070
Why?
Femur Head Necrosis
1
2005
17
0.070
Why?
Neovascularization, Physiologic
1
2005
72
0.070
Why?
Guanosine Triphosphate
1
2004
23
0.060
Why?
Renal Dialysis
1
2007
192
0.060
Why?
Karyotyping
1
2005
92
0.060
Why?
Gene Duplication
1
2005
17
0.060
Why?
Survivors
1
2006
137
0.060
Why?
Tissue Donors
2
2003
110
0.060
Why?
Oncogene Proteins, Fusion
1
2005
60
0.060
Why?
Kidney Transplantation
1
2007
188
0.060
Why?
Thrombophlebitis
1
2004
28
0.060
Why?
Proteolysis
2
2015
102
0.060
Why?
Genomic Instability
1
2005
95
0.060
Why?
Tomography, Emission-Computed
1
2004
53
0.060
Why?
Ferritins
1
2024
31
0.060
Why?
Myeloid Progenitor Cells
1
2023
19
0.060
Why?
X-Ray Microtomography
1
2024
82
0.060
Why?
RNA Interference
2
2015
195
0.060
Why?
Anxiety
1
2005
279
0.060
Why?
Discitis
1
2003
8
0.060
Why?
Stem Cell Factor
1
2003
7
0.060
Why?
Chromatography, High Pressure Liquid
1
2004
377
0.060
Why?
Lymphocyte Transfusion
1
2003
12
0.060
Why?
Confidence Intervals
1
2003
167
0.060
Why?
Patient Selection
1
2005
286
0.060
Why?
Probability
1
2003
176
0.060
Why?
Neoplastic Cells, Circulating
1
2004
93
0.060
Why?
TNF Receptor-Associated Factor 3
1
2022
14
0.060
Why?
Interferons
1
2002
44
0.060
Why?
Infusions, Intravenous
1
2003
231
0.060
Why?
Cyclosporine
1
2003
66
0.050
Why?
Cell Count
1
2003
181
0.050
Why?
Chromosomes, Human, Pair 11
1
2002
54
0.050
Why?
Thyroid Function Tests
1
2002
25
0.050
Why?
Drug Therapy, Combination
2
2017
426
0.050
Why?
Tacrolimus
1
2003
52
0.050
Why?
Geography
1
2022
81
0.050
Why?
Blood Group Incompatibility
1
2002
4
0.050
Why?
ABO Blood-Group System
1
2002
14
0.050
Why?
Thyrotropin
1
2002
46
0.050
Why?
Administration, Oral
1
2003
459
0.050
Why?
Drug Interactions
1
2002
206
0.050
Why?
Fatal Outcome
1
2002
225
0.050
Why?
Chromosome Mapping
3
2006
175
0.050
Why?
Cell Division
1
2002
330
0.050
Why?
RANK Ligand
1
2022
183
0.050
Why?
Graft Survival
1
2002
165
0.050
Why?
Genomics
1
2023
310
0.050
Why?
Acute Disease
1
2002
403
0.050
Why?
Cluster Analysis
3
2006
249
0.050
Why?
Cells, Cultured
1
2005
1737
0.050
Why?
Young Adult
3
2015
4318
0.050
Why?
Tomography, X-Ray Computed
1
2006
1213
0.050
Why?
Neoplasm Transplantation
1
2020
94
0.050
Why?
Depression
1
2005
595
0.050
Why?
3' Untranslated Regions
1
2020
57
0.050
Why?
Odds Ratio
2
2016
604
0.050
Why?
Postoperative Complications
1
2007
1033
0.040
Why?
Pain
1
2003
405
0.040
Why?
Staphylococcal Infections
1
2003
300
0.040
Why?
Positron-Emission Tomography
1
2021
322
0.040
Why?
Crystallography, X-Ray
1
2019
178
0.040
Why?
Antigens, CD
2
2015
242
0.040
Why?
Protein Conformation
1
2019
226
0.040
Why?
Mice, Nude
1
2019
283
0.040
Why?
Coculture Techniques
2
2012
160
0.040
Why?
Antigens, CD19
1
2018
19
0.040
Why?
Mice, Inbred BALB C
1
2019
368
0.040
Why?
Bone Marrow Cells
2
2015
233
0.040
Why?
Receptors, Interleukin-6
1
2018
29
0.040
Why?
Drug Resistance
1
2018
74
0.040
Why?
Microarray Analysis
1
2018
84
0.040
Why?
Disease Management
1
2020
184
0.040
Why?
Protein Stability
1
2018
44
0.040
Why?
Interferon-gamma
2
2010
195
0.040
Why?
Gene Knockdown Techniques
1
2018
125
0.040
Why?
Epidemiologic Methods
2
2008
49
0.040
Why?
Aerobiosis
1
2017
16
0.040
Why?
Microfilament Proteins
1
2017
47
0.040
Why?
Thyroid Hormones
1
2017
18
0.040
Why?
Transplantation, Heterologous
1
2017
77
0.040
Why?
HLA-A Antigens
2
2007
13
0.040
Why?
Calcium-Binding Proteins
1
2017
61
0.040
Why?
Polycomb Repressive Complex 1
1
2016
3
0.040
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
3
0.040
Why?
Cross-Sectional Studies
1
2022
1693
0.040
Why?
Vaccination
2
2010
294
0.040
Why?
Proto-Oncogene Proteins c-myc
1
2017
55
0.040
Why?
Genetic Loci
1
2016
58
0.040
Why?
Mice, Inbred ICR
1
2016
25
0.040
Why?
Antibodies, Neoplasm
2
2006
35
0.030
Why?
Protein Binding
1
2018
736
0.030
Why?
Mice, Knockout
1
2018
926
0.030
Why?
Microscopy, Electron, Transmission
1
2015
87
0.030
Why?
Reoviridae
1
2015
28
0.030
Why?
Genome-Wide Association Study
1
2016
190
0.030
Why?
Tumor Burden
1
2016
142
0.030
Why?
ras Proteins
1
2015
70
0.030
Why?
Receptors, Transferrin
1
2015
17
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
Lentivirus
1
2015
18
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
Repressor Proteins
1
2016
165
0.030
Why?
Adenine
1
2015
44
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
7
0.030
Why?
Molecular Targeted Therapy
1
2016
128
0.030
Why?
Cyclin B
1
2014
6
0.030
Why?
Family
1
2016
193
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
RNA, Messenger
2
2010
1202
0.030
Why?
CDC2 Protein Kinase
1
2014
23
0.030
Why?
Cell Lineage
1
2014
93
0.030
Why?
Reactive Oxygen Species
1
2017
491
0.030
Why?
Disease Models, Animal
2
2013
1639
0.030
Why?
Models, Biological
1
2018
823
0.030
Why?
beta Catenin
1
2015
102
0.030
Why?
Drug Synergism
1
2014
171
0.030
Why?
Piperidines
1
2015
103
0.030
Why?
Mitosis
1
2014
106
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
142
0.030
Why?
Pyrazoles
1
2015
110
0.030
Why?
Cell Movement
1
2015
271
0.030
Why?
Proportional Hazards Models
2
2006
431
0.030
Why?
Peptide Library
1
2013
29
0.030
Why?
Patient Safety
1
2014
121
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Chromosomal Instability
1
2013
17
0.030
Why?
Epitopes
1
2013
89
0.030
Why?
Protein Kinase Inhibitors
1
2014
216
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
55
0.030
Why?
Adolescent
2
2014
6897
0.030
Why?
Immunoglobulin M
1
2012
65
0.030
Why?
Cytomegalovirus
1
2012
30
0.030
Why?
Interleukin Receptor Common gamma Subunit
1
2012
10
0.030
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
11
0.030
Why?
Virus Activation
1
2012
30
0.030
Why?
Viral Load
1
2012
85
0.030
Why?
Interleukin-2
1
2012
75
0.030
Why?
Peripheral Nervous System Diseases
1
2012
63
0.030
Why?
Immunoenzyme Techniques
1
2012
165
0.030
Why?
Viper Venoms
1
2011
7
0.030
Why?
Arkansas
2
2008
2100
0.030
Why?
Asymptomatic Diseases
1
2011
43
0.030
Why?
Neoadjuvant Therapy
1
2012
125
0.030
Why?
Protein C
1
2011
23
0.030
Why?
Chemotherapy, Adjuvant
1
2011
119
0.030
Why?
Lymphocyte Activation
1
2012
197
0.030
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
24
0.020
Why?
Antiviral Agents
1
2012
188
0.020
Why?
CD40 Ligand
1
2010
15
0.020
Why?
Immunoglobulin Idiotypes
1
2010
18
0.020
Why?
Hypersensitivity, Delayed
1
2010
21
0.020
Why?
Interleukin-4
1
2010
48
0.020
Why?
Immunity, Cellular
1
2010
80
0.020
Why?
Adjuvants, Immunologic
1
2010
61
0.020
Why?
Physician's Role
1
2010
55
0.020
Why?
RNA, Small Interfering
1
2010
252
0.020
Why?
Diagnosis, Differential
2
2004
1136
0.020
Why?
Education, Medical, Continuing
1
2010
80
0.020
Why?
Hyperhomocysteinemia
1
2009
30
0.020
Why?
Practice Guidelines as Topic
1
2012
492
0.020
Why?
Protein Isoforms
1
2009
124
0.020
Why?
Indazoles
1
2009
55
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
31
0.020
Why?
Mutation
1
2015
1501
0.020
Why?
Vasculitis
1
2008
30
0.020
Why?
Safety
1
2009
92
0.020
Why?
Ploidies
1
2008
13
0.020
Why?
Algorithms
1
2012
697
0.020
Why?
Haplotypes
1
2008
105
0.020
Why?
Serum Albumin
1
2008
62
0.020
Why?
Twins
1
2007
32
0.020
Why?
Double-Blind Method
1
2009
742
0.020
Why?
Age Distribution
1
2007
198
0.020
Why?
C-Reactive Protein
1
2008
159
0.020
Why?
Multigene Family
1
2006
54
0.020
Why?
CD8-Positive T-Lymphocytes
1
2007
116
0.020
Why?
Creatinine
1
2007
169
0.020
Why?
Partial Thromboplastin Time
1
2006
12
0.020
Why?
Blood Proteins
1
2007
100
0.020
Why?
Cyclin D
1
2006
20
0.020
Why?
Syndecans
1
2006
43
0.020
Why?
Heterozygote
1
2006
96
0.020
Why?
RNA, Neoplasm
1
2006
54
0.020
Why?
Cyclins
1
2006
54
0.020
Why?
HLA-A2 Antigen
1
2005
12
0.020
Why?
Amiloride
1
2005
14
0.020
Why?
Proteoglycans
1
2006
96
0.020
Why?
Transduction, Genetic
1
2005
50
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
191
0.020
Why?
Cell Communication
1
2006
72
0.020
Why?
Radiography
1
2007
524
0.020
Why?
Data Interpretation, Statistical
1
2006
177
0.020
Why?
Cell Line
1
2008
1153
0.020
Why?
Neoplasms, Experimental
1
2006
115
0.020
Why?
Interferon-alpha
1
2005
50
0.020
Why?
Sensitivity and Specificity
1
2007
923
0.020
Why?
Monocytes
1
2005
156
0.020
Why?
Membrane Glycoproteins
1
2006
269
0.020
Why?
Databases, Factual
1
2007
684
0.020
Why?
Clone Cells
1
2004
89
0.020
Why?
Monosomy
1
2003
5
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
240
0.010
Why?
Trisomy
1
2003
34
0.010
Why?
History, 21st Century
1
2003
62
0.010
Why?
Fibroblasts
1
2005
386
0.010
Why?
History, 20th Century
1
2003
114
0.010
Why?
Interphase
1
2003
14
0.010
Why?
Plasmapheresis
1
2003
14
0.010
Why?
Back Pain
1
2003
44
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
9
0.010
Why?
United States
1
2013
5217
0.010
Why?
Anemia
1
2003
84
0.010
Why?
Cohort Studies
1
2006
1543
0.010
Why?
Prevalence
1
2005
1025
0.010
Why?
Quality Assurance, Health Care
1
2003
164
0.010
Why?
DNA, Neoplasm
1
2002
171
0.010
Why?
Erythrocyte Transfusion
1
2002
74
0.010
Why?
Graft Rejection
1
2002
161
0.010
Why?
Kidney Diseases
1
2003
293
0.010
Why?
Anti-Bacterial Agents
1
2003
820
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description